Finch Therapeutics Group, Inc. (FNCH)
NASDAQ: FNCH · IEX Real-Time Price · USD
2.66
-0.05 (-1.85%)
Jul 7, 2022 10:05 AM EDT - Market open
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net Income
|
-58.16 | -39.34 | -20.75 |
| Depreciation & Amortization
|
2.3 | 0.79 | 0.48 |
| Share-Based Compensation
|
4.16 | 3.1 | 0.61 |
| Other Operating Activities
|
-15.44 | 4.12 | 2.35 |
| Operating Cash Flow
|
-67.13 | -31.33 | -17.32 |
| Capital Expenditures
|
-15.92 | -2.63 | -0.97 |
| Investing Cash Flow
|
-15.92 | -2.63 | -0.97 |
| Share Issuance / Repurchase
|
121.8 | 0.06 | 0.15 |
| Debt Issued / Paid
|
-0.03 | 1.76 | 4.73 |
| Other Financing Activities
|
-2.66 | 89.66 | 48.42 |
| Financing Cash Flow
|
119.11 | 91.48 | 53.3 |
| Net Cash Flow
|
36.06 | 57.51 | 35.01 |
| Free Cash Flow
|
-83.05 | -33.96 | -18.29 |
| Free Cash Flow Margin
|
-448.17% | -439.98% | -180.16% |
| Free Cash Flow Per Share
|
-2.12 | -4.17 | -2.51 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).